WallStreetZenWallStreetZen

NASDAQ: STOK
Stoke Therapeutics Inc Stock Ownership - Who owns Stoke Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Stoke Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Edward M. Md KayeDirector2025-10-0825,000$0.60
$15.00kBuy
Edward M. Md KayeDirector2025-10-0825,000$30.00
$750.00kSell
Jonathan AllanGENERAL COUNSEL CORP SEC2025-10-0310,000$25.07
$250.65kSell
Edward M. Md KayeDirector2025-10-0342,461$25.09
$1.07MSell
Jonathan AllanGENERAL COUNSEL CORP SEC2025-10-0310,000$9.15
$91.50kBuy
Barry TichoCHIEF MEDICAL OFFICER2025-10-015,343$23.64
$126.31kSell
Edward M. Md KayeDirector2025-09-0345,996$20.13
$925.85kSell
Jonathan AllanGENERAL COUNSEL CORP SEC2025-09-036,345$20.07
$127.32kSell
Edward M. Md KayeDirector2025-09-0214,860$20.14
$299.27kSell
Barry TichoCHIEF MEDICAL OFFICER2025-09-025,501$19.87
$109.33kSell

1 of 5

STOK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when STOK insiders and whales buy or sell their stock.

STOK Shareholders

What type of owners hold Stoke Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Seth Loring Harrison61.95%33,948,426$1.12BInsider
Apple Tree Partners IV LP31.32%17,161,713$566.34MInsider
Fmr LLC13.53%7,412,982$244.63MInstitution
Blackrock Inc10.81%5,924,567$195.51MInstitution
Lynx1 Capital Management LP9.86%5,404,674$178.35MInstitution
Rtw Investments LP9.35%5,123,525$169.08MInstitution
Baker Bros Advisors LP8.46%4,633,838$152.92MInstitution
Redmile Group LLC7.99%4,375,931$144.41MInstitution
Trust Skorpios7.13%3,906,181$128.90MInsider
Morgan Stanley6.52%3,573,976$117.94MInstitution

1 of 3

STOK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
STOK52.29%47.71%Net SellingNet Selling
EWTX88.36%11.64%Net BuyingNet Selling
SION64.62%35.38%Net BuyingNet Selling
JANX63.40%36.60%Net Buying
HRMY77.54%22.46%Net SellingNet Selling
View Top Biotech Stocks

Stoke Therapeutics Stock Ownership FAQ

Who owns Stoke Therapeutics?

Stoke Therapeutics (NASDAQ: STOK) is owned by 119.62% institutional shareholders, 109.14% Stoke Therapeutics insiders, and 0.00% retail investors. Seth Loring Harrison is the largest individual Stoke Therapeutics shareholder, owning 33.95M shares representing 61.95% of the company. Seth Loring Harrison's Stoke Therapeutics shares are currently valued at $1.07B.

If you're new to stock investing, here's how to buy Stoke Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.